Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.

Haase CL, Tybjærg-Hansen A, Qayyum AA, Schou J, Nordestgaard BG, Frikke-Schmidt R.

J Clin Endocrinol Metab. 2012 Feb;97(2):E248-56. doi: 10.1210/jc.2011-1846. Epub 2011 Nov 16.

PMID:
22090275
2.

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.

Frikke-Schmidt R, Nordestgaard BG, Stene MC, Sethi AA, Remaley AT, Schnohr P, Grande P, Tybjaerg-Hansen A.

JAMA. 2008 Jun 4;299(21):2524-32. doi: 10.1001/jama.299.21.2524.

PMID:
18523221
3.

Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study.

Benn M, Tybjaerg-Hansen A, McCarthy MI, Jensen GB, Grande P, Nordestgaard BG.

J Am Coll Cardiol. 2012 Jun 19;59(25):2356-65. doi: 10.1016/j.jacc.2012.02.043.

4.
5.

Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.

Johannsen TH, Kamstrup PR, Andersen RV, Jensen GB, Sillesen H, Tybjaerg-Hansen A, Nordestgaard BG.

J Clin Endocrinol Metab. 2009 Apr;94(4):1264-73. doi: 10.1210/jc.2008-1342. Epub 2008 Dec 16.

PMID:
19088157
6.

Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.

Haase CL, Tybjærg-Hansen A, Grande P, Frikke-Schmidt R.

J Clin Endocrinol Metab. 2010 Dec;95(12):E500-10. doi: 10.1210/jc.2010-0450. Epub 2010 Sep 8.

PMID:
20826588
7.

No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.

Brøndum-Jacobsen P, Benn M, Afzal S, Nordestgaard BG.

Int J Epidemiol. 2015 Apr;44(2):651-61. doi: 10.1093/ije/dyv078. Epub 2015 May 16.

8.

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.

Jørgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybjærg-Hansen A.

Eur Heart J. 2013 Jun;34(24):1826-33. doi: 10.1093/eurheartj/ehs431. Epub 2012 Dec 17.

9.

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.

Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG.

JAMA. 2009 Jun 10;301(22):2331-9. doi: 10.1001/jama.2009.801.

PMID:
19509380
10.

PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.

Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A.

J Am Coll Cardiol. 2010 Jun 22;55(25):2833-42. doi: 10.1016/j.jacc.2010.02.044. Review.

11.

Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.

Andersen RV, Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard BG.

J Am Coll Cardiol. 2003 Jun 4;41(11):1972-82.

12.

Remnant cholesterol as a causal risk factor for ischemic heart disease.

Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG.

J Am Coll Cardiol. 2013 Jan 29;61(4):427-36. doi: 10.1016/j.jacc.2012.08.1026. Epub 2012 Dec 19.

13.

Identification of genetic variants of lecithin cholesterol acyltransferase in individuals with high HDL‑C levels.

Naseri M, Hedayati M, Daneshpour MS, Bandarian F, Azizi F.

Mol Med Rep. 2014 Jul;10(1):496-502. doi: 10.3892/mmr.2014.2177. Epub 2014 Apr 24.

PMID:
24789697
14.

Milk intake is not associated with ischaemic heart disease in observational or Mendelian randomization analyses in 98,529 Danish adults.

Bergholdt HK, Nordestgaard BG, Varbo A, Ellervik C.

Int J Epidemiol. 2015 Apr;44(2):587-603. doi: 10.1093/ije/dyv109.

15.
16.

TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.

Varbo A, Benn M, Tybjærg-Hansen A, Grande P, Nordestgaard BG.

Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):451-7. doi: 10.1161/ATVBAHA.110.216333. Epub 2010 Nov 11.

17.

High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.

Dullaart RP, Perton F, van der Klauw MM, Hillege HL, Sluiter WJ; PREVEND Study Group.

Atherosclerosis. 2010 Feb;208(2):537-42. doi: 10.1016/j.atherosclerosis.2009.07.042. Epub 2009 Jul 30.

PMID:
19698944
18.

Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study.

Agerholm-Larsen B, Tybjaerg-Hansen A, Schnohr P, Steffensen R, Nordestgaard BG.

Circulation. 2000 Oct 31;102(18):2197-203.

19.

HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study.

Haase CL, Tybjærg-Hansen A, Nordestgaard BG, Frikke-Schmidt R.

Diabetes. 2015 Sep;64(9):3328-33. doi: 10.2337/db14-1603. Epub 2015 May 13.

20.

Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.

Stender S, Frikke-Schmidt R, Nordestgaard BG, Grande P, Tybjaerg-Hansen A.

J Intern Med. 2013 Jan;273(1):59-68. doi: 10.1111/j.1365-2796.2012.02576.x. Epub 2012 Aug 20.

Items per page

Supplemental Content

Write to the Help Desk